Kalytera Therapeutics Israel, Ltd.
1 clinical trials · Sponsor
◉ Watch Kalytera Therapeutics Israel, Ltd.
| Record | Firm | Date |
|---|---|---|
| An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD) (NCT03840512) | Kalytera Therapeutics Israel, Ltd. | 2018-06-12 |
Track Kalytera Therapeutics Israel, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.